Anna C Cole

6PUBLICATIONS
24CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 06, 2026
TLR9 Agonists Potentiate Adoptive T Cell Therapy in Cancer through a B Cell-CD2 Costimulatory Axis.

|Dec 05, 2025
T-cell Priming by High-Avidity Neoantigens in Lymph Nodes Augments Adoptive Immunotherapy.

Megen C Wittling, Amalia M Rivera-Reyes, Megan M Wyatt

|Jun 30, 2024
Distinct host preconditioning regimens differentially impact the antitumor potency of adoptively transferred Th17 cells.

Megen C Wittling, Hannah M Knochelmann, Megan M Wyatt

|Jan 30, 2024
IL15 and IL21: Better When Membrane-Tethered Together on Antitumor T Cells.

Ayana T Ruffin, Megen C Wittling, Anna C Cole

|Jan 08, 2024
Distinct host preconditioning regimens differentially impact the antitumor potency of adoptively transferred Th17 cells.

Megen C Wittling, Hannah M Knochelmann, Megan M Wyatt

|Oct 06, 2023
Progressively Enhancing Stemness of Adoptively Transferred T Cells with PI3Kδ Blockade Improves Metabolism and Antitumor Immunity.

Guillermo O Rangel Rivera, Connor J Dwyer, Hannah M Knochelmann

Pageof 1

Frequent Collaborators

6 joint publications

Chrystal M Paulos

5 joint publications

Gregory B Lesinski

5 joint publications

Megen C Wittling

4 joint publications

Guillermo O Rangel Rivera